FA
TMO icon

FMA Advisory’s Thermo Fisher Scientific TMO Stock Holding History

FMA Advisory’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$8.71M Sell
15,239
-83
-0.5% -$45.6K 3.25% 3
2021
Q2 		$7.73M Buy
15,322
+152
+1% +$71.7K 2.87% 3
2021
Q1 		$6.92M Buy
15,170
+88
+0.6% +$42K 2.14% 3
2020
Q4 		$7.03M Buy
15,082
+183
+1% +$85.8K 2.34% 3
2020
Q3 		$6.58M Buy
14,899
+28
+0.2% +$11.6K 2.62% 3
2020
Q2 		$5.39M Buy
14,871
+33
+0.2% +$11.1K 2.42% 4
2020
Q1 		$4.21M Sell
14,838
-406
-3% -$128K 2.29% 5
2019
Q4 		$4.95M Sell
15,244
-11
-0.1% -$3.33K 1.99% 7
2019
Q3 		$4.44M Buy
15,255
+6
+0% +$1.72K 1.93% 11
2019
Q2 		$4.48M Buy
15,249
+148
+1% +$40.8K 1.99% 9
2019
Q1 		$4.13M Buy
15,101
+5
+0% +$1.24K 1.89% 9
2018
Q4 		$3.38M Buy
15,096
+112
+0.7% +$26.3K 1.75% 11
2018
Q3 		$3.66M Buy
14,984
+77
+0.5% +$17.7K 1.64% 13
2018
Q2 		$3.09M Buy
14,907
+100
+0.7% +$21.2K 1.45% 16
2018
Q1 		$3.06M Buy
14,807
+479
+3% +$101K 1.49% 17
2017
Q4 		$2.72M Buy
14,328
+1,395
+11% +$267K 1.28% 21
2017
Q3 		$2.45M Buy
12,933
+329
+3% +$59.6K 1.43% 18
2017
Q2 		$2.2K Sell
12,604
-77
-0.6% -$12.9K 1.13% 22
2017
Q1 		$1.95M Buy
+12,681
New +$1.94M 0.99% 35
2015
Q2 		$818K Buy
+6,305
New +$822K 0.51% 58
2014
Q4 		$1.49M Sell
11,923
-267
-2% -$32.5K 0.52% 76
2014
Q3 		$1.48M Sell
12,190
-332
-3% -$40.4K 0.55% 73
2014
Q2 		$1.48M Sell
12,522
-241
-2% -$28.4K 0.54% 74
2014
Q1 		$1.53M Sell
12,763
-147
-1% -$17.5K 0.6% 66
2013
Q4 		$1.44M Sell
12,910
-145
-1% -$14.4K 0.59% 65
2013
Q3 		$1.2M Sell
13,055
-243
-2% -$22K 0.48% 76
2013
Q2 		$1.13M Buy
+13,298
New +$1.11M 0.47% 79

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FMA Advisory's TMO Position: Q3 2021 in Review

FMA Advisory reduced its Thermo Fisher Scientific (TMO) stake by 0.54% in Q3 2021, selling an estimated $45.6K and leaving 15,239 shares worth $8.71M. The position accounts for 3.25% of the portfolio, ranked #3.

FMA Advisory first reported a position in TMO in Q2 2013 and has held it in 27 quarters since. 2,128 funds tracked by Wall St. Rank hold TMO as of Q3 2021.

  • FMA Advisory held 15,239 shares of Thermo Fisher Scientific worth $8.71M as of Q3 2021.
  • FMA Advisory sold 83 Thermo Fisher Scientific shares in Q3 2021, an estimated $45.6K.
  • Thermo Fisher Scientific made up 3.25% of FMA Advisory's portfolio in Q3 2021, its #3 holding.
  • FMA Advisory first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 27 quarters since.
  • 2,128 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2021.

Based on FMA Advisory's 13F filing for Q3 2021, filed 15 Nov 2021.